Penn Medicine Provider
Gastroenterology
Ben Stanger, MD, PhD
Accepting new patients
Sees patients age 18 and up
Penn Gastroenterology Radnor

About me

  • Director, Penn Pancreatic Cancer Research Center (PCRC)
  • Hanna Wise Professor in Cancer Research
  • Professor of Medicine in Cell and Developmental Biology

Education and training

  • Medical School: Harvard Medical School
  • Residency: UCSF Medical Center and Hospital
  • Fellowship: Massachusetts General Hospital

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: On the medical staff, but does not have privileges to treat patients in the hospital.
Dr. Stanger is a Penn Medicine physician.

Qualifications and experience

My research

Katsuda T, Sussman JH, Ito K, Katznelson A, Yuan S, Takenaka N, Li J, Merrell AJ, Cure H, Li Q, Rasool RU, Asangani IA, Zaret KS, Stanger BZ Cellular reprogramming in vivo initiated by SOX4 pioneer factor activity , Nat Commun, 15(1): 2024,1761


Kim I-K, Diamond MS, Yuan S, Kemp SB, Kahn BM, Li Q, Lin JH, Li J, Norgard RJ, Thomas SK, Merolle M, Katsuda T, Tobias JW, Baslan T, Politi K, Vonderheide RH, Stanger BZ Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma , Nat Commun, 15(1): 2024,1532


Kemp SB, Cheng N, Markosyan N, Sor R, Kim I-K, Hallin J, Shoush J, Quinones L, Brown NV, Bassett JB, Joshi N, Yuan S, Smith M, Vostrejs WP, Perez-Vale KZ, Kahn B, Mo F, Donahue TR, Radu CG, Clendenin C, Christensen JG, Vonderheide RH, Stanger BZ Efficacy of a small molecule inhibitor of KrasG12D in immunocompetent models of pancreatic cancer , Cancer Discov, 13(2): 2023,298-311


Maddipati R, Norgard RJ, Baslan T, Rathi KS, Zhang A, Saeid A, Higashihara T, Wu F, Kumar A, Annamalai V, Bhattacharya S, Raman P, Adkisson CA, Pitarresi JR, Wengyn MD, Yamazoe T, Millstein ID, Bermeo J, Carpenter EL, McAuliffe, Oktay MH, Brekken RA, Lowe SW, lacobuzio-Donahue CA, Notta F, Stanger BZ. MYC levels regulate metastatic heterogeneity in pancreatic adenocarcinoma , Cancer Discov, 12(2): 2022,542-561


Sela Y, Li J, Maheswaran S, Norgard RJ, Yuan S, Hubbi ME, Doepner M, Xu JP, Ho ES, Mesaros C, Sheehan C, Croley G, Muir A, Blair IA, Shalem O, Dang CV, Stanger BZ Bcl-xL enforces a slow-cycling state necessary for survival in the nutrient-deprived microenvironment of pancreatic cancer , Cancer Res, 82(10): 2022,1890-1908


Li J, Yuan S, Norgard RJ, Yan F, Sun YH, Kim IK, Merrell AJ, Sela Y, Jiang Y, Bhanu NV, Garcia BA, Vonderheide RH, Blanco A, Stanger BZ. Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor Regulates the Tumor Immune Microenvironment in Pancreatic Cancer , Cancer Discov., 11(3): 2021,736-753


Li J, Stanger BZ The tumor as organizer model , Science, 363(6431): 2019,1038-1039


Ben Stanger From One Cell: A Journey into Life's Origins and the Future of Medicine , W.W. Norton: 2023


View all publications